ID

16041

Beschrijving

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications; ODM derived from: https://clinicaltrials.gov/show/NCT02320721

Link

https://clinicaltrials.gov/show/NCT02320721

Trefwoorden

Versies (1)
  1. 27-06-16 27-06-16 -
Geüploaded op

27 juni 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 2 Diabetes Mellitus NCT02320721

Engels

Eligibility Type 2 Diabetes Mellitus NCT02320721

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients ≥65 years old with type 2 diabetes mellitus, inadequately controlled on antidiabetic regimens either including no insulin, or with basal insulin as their only insulin.
Beschrijving

Age | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Therapy Controlled Inadequate | Insulin Absent | Basal insulin

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0011860
UMLS CUI [3,1]
C3274787
UMLS CUI [3,2]
C2587213
UMLS CUI [3,3]
C0205412
UMLS CUI [4,1]
C0021641
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C0650607
signed informed consent.
Beschrijving

Informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
hba1c at screening visit:
Beschrijving

Glycosylated hemoglobin A

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
<7.0% or >10.0% for patients taking basal insulin.
Beschrijving

Basal insulin

Datatype

boolean

Alias
UMLS CUI [1]
C0650607
<7.5% or >11.0% for insulin-naïve patients.
Beschrijving

Insulin Therapy naive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
history of type 2 diabetes mellitus for less than 1 year before screening.
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent disease length

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
patients not on stable basal insulin dose (±10% in the last 8 weeks prior to screening visit).
Beschrijving

Basal insulin Dose Unstable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0650607
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0443343
change in dose of antidiabetic treatment or initiation of new glucose-lowering medications in the last 8 weeks prior to screening.
Beschrijving

Diabetes Therapy Dose Change | Initiation Pharmaceutical Preparations Glucose Lowering

Datatype

boolean

Alias
UMLS CUI [1,1]
C3274787
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0392747
UMLS CUI [2,1]
C1704686
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0017725
UMLS CUI [2,4]
C2003888
chronic (>10 days continuous use in previous 6 months) use of bolus insulin injections, whether given separately or as part of a combination with basal insulin, eg, premix insulin; for insulin-naïve individuals: current or previous insulin use except for a maximum of 10 consecutive days (e.g. acute illness, surgery) during the last year prior to screening.
Beschrijving

bolus infusion Insulin chronic | bolus infusion Insulin Combined Basal insulin | Insulin Therapy naive | Acute illness | Operative Surgical Procedures

Datatype

boolean

Alias
UMLS CUI [1,1]
C1511237
UMLS CUI [1,2]
C0021641
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C1511237
UMLS CUI [2,2]
C0021641
UMLS CUI [2,3]
C0205195
UMLS CUI [2,4]
C0650607
UMLS CUI [3,1]
C0021641
UMLS CUI [3,2]
C0919936
UMLS CUI [4]
C4061114
UMLS CUI [5]
C0543467
cognitive disorder and dementia assessed clinically and by mini-mental state examination (mmse) score <24, or any neurologic disorder that will likely affect the patient's ability to follow the study procedure. the patient will be eligible despite an mmse score <24 if the investigator determines that the low score reflects educational or cultural background and not dementia as long as the patient is otherwise able to meet the study requirements.
Beschrijving

Cognition Disorders | Dementia | Mini-mental state examination | nervous system disorder Affecting Compliance behavior

Datatype

boolean

Alias
UMLS CUI [1]
C0009241
UMLS CUI [2]
C0497327
UMLS CUI [3]
C0451306
UMLS CUI [4,1]
C0027765
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C1321605
patients who have end-stage renal disease (<15 ml/min/1.73m^2, per estimated glomerular filtration rate [egfr] measurement by modification of diet in renal disease [mdrd]).
Beschrijving

Kidney Failure, Chronic | Estimated Glomerular Filtration Rate Modification of diet in renal disease formula

Datatype

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2,1]
C3811844
UMLS CUI [2,2]
C3839656
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
Terug naar het begin van de pagina

Similar models

Eligibility Type 2 Diabetes Mellitus NCT02320721

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Therapy Controlled Inadequate | Insulin Absent | Basal insulin
Item
patients ≥65 years old with type 2 diabetes mellitus, inadequately controlled on antidiabetic regimens either including no insulin, or with basal insulin as their only insulin.
boolean
C0001779 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C3274787 (UMLS CUI [3,1])
C2587213 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
C0021641 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0650607 (UMLS CUI [5])
Informed consent
Item
signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Glycosylated hemoglobin A
Item
hba1c at screening visit:
boolean
C0019018 (UMLS CUI [1])
Basal insulin
Item
<7.0% or >10.0% for patients taking basal insulin.
boolean
C0650607 (UMLS CUI [1])
Insulin Therapy naive
Item
<7.5% or >11.0% for insulin-naïve patients.
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent disease length
Item
history of type 2 diabetes mellitus for less than 1 year before screening.
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Basal insulin Dose Unstable
Item
patients not on stable basal insulin dose (±10% in the last 8 weeks prior to screening visit).
boolean
C0650607 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0443343 (UMLS CUI [1,3])
Diabetes Therapy Dose Change | Initiation Pharmaceutical Preparations Glucose Lowering
Item
change in dose of antidiabetic treatment or initiation of new glucose-lowering medications in the last 8 weeks prior to screening.
boolean
C3274787 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
C1704686 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0017725 (UMLS CUI [2,3])
C2003888 (UMLS CUI [2,4])
bolus infusion Insulin chronic | bolus infusion Insulin Combined Basal insulin | Insulin Therapy naive | Acute illness | Operative Surgical Procedures
Item
chronic (>10 days continuous use in previous 6 months) use of bolus insulin injections, whether given separately or as part of a combination with basal insulin, eg, premix insulin; for insulin-naïve individuals: current or previous insulin use except for a maximum of 10 consecutive days (e.g. acute illness, surgery) during the last year prior to screening.
boolean
C1511237 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C1511237 (UMLS CUI [2,1])
C0021641 (UMLS CUI [2,2])
C0205195 (UMLS CUI [2,3])
C0650607 (UMLS CUI [2,4])
C0021641 (UMLS CUI [3,1])
C0919936 (UMLS CUI [3,2])
C4061114 (UMLS CUI [4])
C0543467 (UMLS CUI [5])
Cognition Disorders | Dementia | Mini-mental state examination | nervous system disorder Affecting Compliance behavior
Item
cognitive disorder and dementia assessed clinically and by mini-mental state examination (mmse) score <24, or any neurologic disorder that will likely affect the patient's ability to follow the study procedure. the patient will be eligible despite an mmse score <24 if the investigator determines that the low score reflects educational or cultural background and not dementia as long as the patient is otherwise able to meet the study requirements.
boolean
C0009241 (UMLS CUI [1])
C0497327 (UMLS CUI [2])
C0451306 (UMLS CUI [3])
C0027765 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C1321605 (UMLS CUI [4,3])
Kidney Failure, Chronic | Estimated Glomerular Filtration Rate Modification of diet in renal disease formula
Item
patients who have end-stage renal disease (<15 ml/min/1.73m^2, per estimated glomerular filtration rate [egfr] measurement by modification of diet in renal disease [mdrd]).
boolean
C0022661 (UMLS CUI [1])
C3811844 (UMLS CUI [2,1])
C3839656 (UMLS CUI [2,2])
Study Subject Participation Status
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial